Why do some people do more for the community than others? A new study from the University of Zurich now shows that personality traits such as extraversion and agreeableness correlate with volunteering and charitable giving.

 

A new report calls for an end to austerity, and sustainable long-term economic and social policies for coalfield areas.

Researchers from University of Staffordshire, University of Cambridge and University of Leeds have examined the long-term impact of the loss of the coal industry in former coal-producing areas of the UK.

The report focuses on a number of coalfield areas; Fife and South Lanarkshire (Scotland) Barnsley and Stoke on Trent (England) and Neath/Port Talbot and Merthyr Tydfil (Wales).

Based in some of the most deprived regions of the UK, the researchers claim that successive Governments have failed these communities and are calling for a new type of sustained and long-term industrial policy.

An infectious diseases detection platform developed by University of Pittsburgh scientists working with UPMC infection preventionists proved over a two-year trial that it stops outbreaks, saves lives and cuts costs, making the case for development of a national early outbreak detection database.

Researchers from Texas McCombs School of Business found that positive emotions from coaches or consulting team leaders during the beginning phase of a project improved team members’ individual performance. But performance improved even further when leaders occasionally leaned into negative expressions during the project's middle phase.

Even for patients covered by Medicare, annual out-of-pocket costs for lifesaving cancer treatments taken in pill form have often exceeded $10,000—until recently. Thanks to changes in Medicare Part D introduced by the Inflation Reduction Act (IRA) that took effect in 2025, annual out-of-pocket drug costs for all beneficiaries are now capped at $2,000. However, an overlooked voluntary program that’s part of the IRA could be the key to improving affordability for Medicare patients needing expensive oral cancer drugs, according to a new study from researchers from the Perelman School of Medicine at the University of Pennsylvania published today in JCO Oncology Practice.